医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| N,N-二甲基喹啉-2-胺 | N,N-dimethylquinolin-2-amine | 21154-18-7 | C11H12N2 |
| N,N-二甲基吡啶-3-胺 | 3-dimethylaminopyridine | 18437-57-5 | C7H10N2 |
| N,N-二甲基吡啶-2,5-二胺 | N2,N2-dimethylpyridine-2,5-diamine | 4928-43-2 | C7H11N3 |
| N,N-二甲基-N-辛基氯化1-癸铵 | Decyldimethyloctylammonium chloride | 32426-11-2 | C20H44ClN |
| N,N-二甲基-5-硝基-2-吡啶胺 | N,N-dimethyl-5-nitropyridin-2-amine | 2554-75-8 | C7H9N3O2 |
| N,N-二甲基-4-[2-(2-喹啉基)乙烯基]苯胺 | 2-{4-Dimethylamino-styryl}-quinoline | 1612-64-2 | C19H18N2 |
| N,N-二甲基-4,4-偶氮二苯胺 | N,N-dimethyl-4,4'-azodianiline | 539-17-3 | C14H16N4 |
| N,N-二甲基-3-氯丙胺 | 3-(Dimethylamino)propyl chloride | 109-54-6 | C5H12ClN |
| N,N-二甲基-2-[(O-甲基-alpha-苯基苄基)氧基]乙胺 N-氧化物 | orphenadrine N-oxide | 29215-00-7 | C18H23NO2 |
| N,N-二丙基色胺 | N,N-dipropyltryptamine | 61-52-9 | C16H24N2 |
| N,N-二丙基三氟甲磺酰胺 | N,N-dipropyltrifluoromethanesulfonamide | 1242695-00-6 | C7H14F3NO2S |
| N,N-二boc-2-氨基-4-溴吡啶 | di-tert-butyl (4-bromopyridin-2-yl)iminodicarbonate | 1216620-65-3 | C15H21BrN2O4 |
| N,N-二-BOC-2-氨基吡啶 | N,N-Di-Boc-2-aminopyridine | 870703-63-2 | C15H22N2O4 |
| N,N-二-BOC-2-氨基-6-氯嘧啶 | tert-butyl N-tert-butoxycarbonyl-N-(6-chloropyrimidin-4-yl)carbamate | 354112-08-6 | C14H20ClN3O4 |
| N,N-二(2-吡啶甲基)炔丙氨 | N-propargyl-N,N-bis(2-pyridylmethyl)amine | 950984-75-5 | C15H15N3 |
| N,N,N’,N’-四((对二异丁基)氨基苯基)对苯二胺 | (N,N,N’,N’-tetrakis(p-diisobutylaminophenyl)-p-phenylenediamine) | 485831-34-3 | C62H92N6 |
| N,N,N’,N’-四(4-二丁基氨基苯基)-1,4-苯二胺 | N,N,N’,N’-tetrakis[p-di(butyl)aminophenyl]-p-phenylene | 4182-80-3 | C62H92N6 |
| N,N,N,N-四-(2-吡啶基甲基)乙二胺 | TPEN | 16858-02-9 | C26H28N6 |
| N,N,N',N'-四(4-醛基苯基)-1,4-苯二胺 | 4,4',4'',4'''-([1,1'-biphenyl]-4,4'-diylbis(azanetriyl))tetrabenzaldehyde | 865448-72-2 | C40H28N2O4 |
| N,N,N',N'-四苯基联苯胺 | N,N,N',N'-tetraphenyl-4,4'-diaminobiphenyl | 15546-43-7 | C36H28N2 |
| N,N,2-三甲基喹啉-6-胺 | N,N,2-trimethylquinolin-6-amine | 92-99-9 | C12H14N2 |
| N,N'-双[4-二(间甲苯基)氨基苯基]-N,N'-二苯基联苯胺 | Dntpd | 199121-98-7 | C64H54N4 |
| N,N'-双-(4-吡啶基)苯四甲酰亚胺 | N,N'-di-(4-pyridyl)-1,2,4,5-benzenetetracarboxydiimide | 34072-51-0 | C20H10N4O4 |
| N,N'-双-(2-吡啶基)苯四甲酰亚胺 | N,N'-Di-(2-pyridyl)-pyromellitimid | 31663-81-7 | C20H10N4O4 |
| N,N'-二苯基-N,N'-(1-萘基)-1,1'-联苯-4,4'-二胺 | 4,4'-bis[N-(1-naphthyl)-N-phenylamino] biphenyl | 123847-85-8 | C44H32N2 |
| N,N'-二苄基乙二胺二醋酸 | N,N'-dibenzylethylenediamine diacetate | 122-75-8 | 2C2H4O2*C16H20N2 |
| N,N'-二甲基苯并咪唑鎓碘化物 | 1,3-dimethylbenzimidazolium Iodide | 7181-87-5 | C9H11N2*I |
| N,N'-二氧化-2,2'-联吡啶 | [2,2']bipyridinyl 1,1'-dioxide | 7275-43-6 | C10H8N2O2 |
| N,N'-二(2,6-二甲基苯基)草酰胺 | N,N’-2,6-dimethylphenyl-oxamide | 91325-47-2 | C18H20N2O2 |
| N,N'-二(2,3-二羟基丙基)-5-[(羟基乙酰基)氨基]-2,4,6-三碘-1,3-苯二甲酰胺 | 5-(2-hydroxyacetamido)-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide | 77868-40-7 | C16H20I3N3O8 |
| N,N'-二(11-羟烷基)-4,4'-联吡啶二高氯酸盐 | N,N'-Bis(11hydroxyundecanyl)bipyridinium diperchlorate | 214207-81-5 | C32H54Cl2N2O10 |
| N,N'-丙烷二亚基二苯胺 | Malondialdehyd-dianil | 5652-79-9 | C15H14N2 |
| N,N'-1,2-乙二醛二苯胺 | Glyoxaldianil | 30834-75-4 | C14H12N2 |
| N,N''-二[[(4-氯苯基)氨基]亚氨基甲基]哌嗪-1,4-二甲脒二盐酸盐 | Picloxydine dihydrochloride | 19803-62-4 | C20H26Cl4N10 |
| N,N''-(亚甲基二-4,1-亚苯基)二[N'-十八烷基脲] | 3,3'-Dioctadecyl-1,1'-methylenebis(4,1-phenylene)diurea | 43136-14-7 | C51H88N4O2 |
| N(3)-甲基-2'-脱氧胞苷 | 4-methylamino-1-(β-D-2-deoxyribofuranosyl)pyrimidin-2(1H)-one | 22882-02-6 | C10H15N3O4 |
| N'-(2-氰基-4-硝基苯基)-N,N-二甲基亚胺甲酰胺 | N'-(2-cyano-4-nitrophenyl)-N,N-dimethylformimidamide | 39263-34-8 | C10H10N4O2 |
| MK-5172中间体 | (S)-3,3-dimethyl-2-((((1R,2R)-2-(pent-4-yn-1-yl)cyclopropoxy)carbonyl)amino)butanoic acid tert-butylamine salt | 1425038-21-6 | C4H11N*C15H23NO4 |
| MK-5172中间体 | methyl (1aR,5S,8S,10R,22aR)-5-tert-butyl-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxa-diazacyclononadecino[11,12-b]quinoxaline-8-carboxylate | 1206524-84-6 | C30H40N4O7 |
| LY2157299(中间体) | 1-(amino)-2-pyrollidinone p-toluenesulfonate | 924898-12-4 | C4H8N2O*C7H8O3S |
| LOXO101的中间体 | 3-nitropyrazolo[1,5-a]pyrimidin-5(4H)-one | 1919868-75-9 | C6H4N4O3 |
| LCZ696中间体 | (S)-(-)-5-(4'-phenylbenzoyl)-2-pyrrolidinone | 195137-95-2 | C17H15NO2 |
| L-青霉胺 | L-penicillamine | 1113-41-3 | C5H11NO2S |
| L-赖氨酰-L-alpha-天冬氨酰-L-异亮氨酰-N5-(氨基羰基)-L-鸟氨酰胺 | Tripeptide-10 citrulline | 960531-53-7 | C22H42N8O7 |
| L-脯氨酸与(1S)-1,5-脱水-1-C-[3-(苯并[b]噻吩-2-基甲基)-4-氟苯基]-D-山梨糖醇的化合物 | Ipragliflozin L-proline | 951382-34-6 | C5H9NO2*C21H21FO5S |
| L-肌苷 | Riboxine | 21138-24-9 | C10H12N4O5 |
| L-甘油醛缩丙酮 | (4S)-2,2-dimethyl-[1,3]dioxolane-4-carbaldehyde | 22323-80-4 | C6H10O3 |
| L-墨蝶呤 | sepiapterin | 17094-01-8 | C9H11N5O3 |
| L-古洛糖酸 | <i>dl</i>-gulonic acid | 526-97-6 | C6H12O7 |
| L-叔亮酰胺盐酸盐 | (S)-2-amino-3,3-dimethylbutanamide hydrochloride | 75158-12-2 | C6H14N2O*ClH |